Edina I. Szabo

Pecs, BA 7624, Hungary

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 26 publications

PACAP and its receptors in the retina of various species.

PACAP and its receptors in the retina of various species.

Journal: Neuropeptides

Published: March 02, 2026

Protective Effects of PACAP in Diabetic Complications: Retinopathy, Nephropathy and Neuropathy.

Protective Effects of PACAP in Diabetic Complications: Retinopathy, Nephropathy and Neuropathy.

Journal: International journal of molecular sciences

Published: September 09, 2025

Retinoprotective Effects of Abscisic Acid in Ischemic Retinopathy Mouse Model.

Retinoprotective Effects of Abscisic Acid in Ischemic Retinopathy Mouse Model.

Journal: Antioxidants (Basel, Switzerland)

Published: August 21, 2025

PAC1 receptor agonist maxadilan alleviates corneal inflammation in a murine model of LPS-induced ocular inflammation.

PAC1 receptor agonist maxadilan alleviates corneal inflammation in a murine model of LPS-induced ocular inflammation.

Journal: PloS one

Published: July 03, 2025

BM-164 (an H₂S-donor) modulates microRNA expression associated with reperfusion-induced ventricular fibrillation in rat hearts.

BM-164 (an H₂S-donor) modulates microRNA expression associated with reperfusion-induced ventricular fibrillation in rat hearts.

Journal: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences

Published: July 02, 2025

Combined Herbal Eye Drops Exhibit Neuroprotective and Intraocular Pressure-Reducing Effects in a Glaucoma Rat Model.

Combined Herbal Eye Drops Exhibit Neuroprotective and Intraocular Pressure-Reducing Effects in a Glaucoma Rat Model.

Journal: Antioxidants (Basel, Switzerland)

Published: March 30, 2025

The Protective Effect of Topical PACAP38 in Retinal Morphology and Function of Type 2 Diabetic Retinopathy.

The Protective Effect of Topical PACAP38 in Retinal Morphology and Function of Type 2 Diabetic Retinopathy.

Journal: International journal of molecular sciences

Published: February 14, 2025

Investigation of PACAP38 and PAC1 Receptor Expression in Human Retinoblastoma and the Effect of PACAP38 Administration on Human Y-79 Retinoblastoma Cells.

Investigation of PACAP38 and PAC1 Receptor Expression in Human Retinoblastoma and the Effect of PACAP38 Administration on Human Y-79 Retinoblastoma Cells.

Journal: Life (Basel, Switzerland)

Published: December 18, 2023

Protective Effects of Pituitary Adenylate-Cyclase-Activating Polypeptide on Retinal Vasculature and Molecular Responses in a Rat Model of Moderate Glaucoma.

Protective Effects of Pituitary Adenylate-Cyclase-Activating Polypeptide on Retinal Vasculature and Molecular Responses in a Rat Model of Moderate Glaucoma.

Journal: International journal of molecular sciences

Published: July 30, 2023

Well-Trained Elders Have Antioxidant Responses and an Equal Magnitude of EIMD as Young Adults.

Well-Trained Elders Have Antioxidant Responses and an Equal Magnitude of EIMD as Young Adults.

Journal: International journal of environmental research and public health

Published: June 16, 2022

Distribution of PACAP and PAC1 Receptor in the Human Eye.

Distribution of PACAP and PAC1 Receptor in the Human Eye.

Journal: Journal of molecular neuroscience : MN

Published: January 15, 2022

Retinoprotective Effects of PACAP Eye Drops in Microbead-Induced Glaucoma Model in Rats.

Retinoprotective Effects of PACAP Eye Drops in Microbead-Induced Glaucoma Model in Rats.

Journal: International journal of molecular sciences

Published: July 15, 2021

Showing 1-12 of 26

Last Updated: 09/26/2026